Table 1 Clinical and laboratory characteristics of IBD patients
From: Hidden musculoskeletal involvement in inflammatory bowel disease: a multicenter ultrasound study
Crohn’s disease/Ulcerative colitis | 43/33 patients |
Age | 39.93 ± 14.02 years |
BMI | 23.36 ± 4.13 kg/m2 |
Disease duration | 7.91 ± 6.18 years |
Active/inactive bowel disease | 51.3 %/48.7 % |
Disease flares | 2.53 ± 1.97 |
ASCA positive | 25 % (CD) |
pANCA positive | 18.4 % (17 % UC + 1.4 % CD) |
HLA B 27 positive | 2.6 % |
CRP | 0.69 ± 0.96 mg/dL |
ESR | 14.52 ± 11.48 mm/h |
Medications | |
- Corticosteroids | 19.7 % |
- 5 ASA | 42.1 % |
- Anti-TNFα | 32.9 % |
- Azathioprine | 28.9 % |
- Cyclosporine | 1.3 % |